Affiliations: Tempus, Chicago, IL

Areas of specialization: breast cancer in younger women, breast cancer angiogenesis, hormonal therapy, neoadjuvant therapy for breast cancer

Dr. Blackwell is chief medical adviser for Tempus, a company that develops novel technology that generates, collects, structures, and analyzes large amounts of data to create genomic tests, companion diagnostics, clinical trial matching software, and other solutions for precision medicine. She joined Tempus from Eli Lilly, where she was vice president of early-phase oncology and immuno-oncology. Prior to that, she was professor of medicine and assistant professor of radiation oncology at Duke University, where she directed the Women’s
Cancer Program, Strategic Collaborations, and the Precision Medicine Initiative for the Duke Cancer Institute.